Catalyst
Slingshot members are tracking this event:
Radius Health (RDUS) to Complete Phase III Testing in October 2016 for Abaloparatide-SC in Postmenopausal Osteoporosis
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| RDUS |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 16, 2016
Occurred Source:
http://investors.radiuspharm.com/releasedetail.cfm?ReleaseID=984545
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase Iii Testing, Abaloparatide-sc, Postmenopausal Women
